Clinician Utilization Data |
|
HCPCS Procedural Code
|
HCPCS Code Description
|
Beneficiary Count
|
Service Count
|
|
17000
|
Destruction of skin growth
|
12
|
13
|
|
71046
|
X-ray of chest, 2 views
|
79
|
91
|
|
73030
|
X-ray of shoulder, minimum of 2 views
|
26
|
30
|
|
73502
|
X-ray of hip with pelvis, 2-3 views
|
18
|
21
|
|
73562
|
X-ray of knee, 3 views
|
20
|
21
|
|
76536
|
Ultrasound of head and neck
|
15
|
16
|
|
76942
|
Ultrasonic guidance imaging supervision and interpretation for insertion of needle
|
12
|
13
|
|
80305
|
Testing for presence of drug
|
80
|
382
|
|
83036
|
Hemoglobin a1c level
|
306
|
450
|
|
85025
|
Complete blood cell count (red cells, white blood cell, platelets), automated test
|
455
|
978
|
|
92540
|
Observation, testing, and recording of abnormal eye movement
|
12
|
12
|
|
93000
|
Routine ekg using at least 12 leads including interpretation and report
|
65
|
68
|
|
93880
|
Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
|
32
|
34
|
|
93922
|
Ultrasound study of arteries of both arms and legs
|
61
|
70
|
|
93925
|
Ultrasound study of arteries and arterial grafts of both legs
|
43
|
44
|
|
93970
|
Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers
|
46
|
49
|
|
93971
|
Ultrasound scan of veins of one arm or leg or limited including assessment of compression and functional maneuvers
|
11
|
12
|
|
94010
|
Measurement and graphic recording of total and timed exhaled air capacity
|
19
|
20
|
|
96132
|
Neuropsychological testing evaluation by qualified health care professional, first 60 minutes
|
12
|
12
|
|
96372
|
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
|
208
|
344
|
|
97112
|
Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes
|
27
|
178
|
|
97140
|
Manual (physical) therapy techniques to 1 or more regions, each 15 minutes
|
27
|
89
|
|
G0008
|
Administration of influenza virus vaccine
|
79
|
80
|
|
G0180
|
Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
|
27
|
31
|
|
G0439
|
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
249
|
249
|
|
J1100
|
Injection, dexamethasone sodium phosphate, 1 mg
|
137
|
744
|
|
J3301
|
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
21
|
87
|